Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

This is the story of how, like Mr. Smith in Washington, the medical community in Brazil gathered to speak truth to power about the lack of evidence for phosphoethanolamine as a cancer treatment.
This is the story of how a populist Congress approved the medication that wasn't, and oncologists in the country are waiting to see if an enfeebled president will be able to veto the bill.
This is the story of how an eager chemistry professor and a well-intended but misguided federal judge transformed cancer care and drug development in Brazil into a convoluted soap opera.
ASCO CEO Dr. Allen S. Lichter reflects on an optimistic approach to the challenges of providing high-quality cancer care around the globe on World Cancer Day.
The decision to scale up the provision of oral chemotherapy was a watershed event in the regulation of private health insurance in Brazil; however, prospects for expanded access to such medicines in the public health system are bleak in the short term.
Price discrimination is an inequitable-sounding, but important, concept of charging different prices for the same product or service in different markets or segments of a market, usually based on consumers’ ability to pay.
Few readers will remember Kenneth Feinberg. A lawyer by profession, in the wake of 9/11 and more recent tragedies such as the Boston Marathon bombing, he was responsible for answering the unanswerable question: How much is a human life worth?